Abstract
CECIL is a database that stores clinical and molecular information on patients with Alport syndrome. The clinical component of CECIL is specific to Alport syndrome; the component that stores and manipulates molecular data can be used for any disease caused by a gene mutation, such as cystic fibrosis. While offering the ability to retrieve patient data through compound Boolean queries, CECIL also offers the ability to manipulate sequence information in various ways. In particular, CECIL can perform an augmented sequence alignment of an abnormal (patient) DNA sequence with a reference sequence. CECIL is currently being used by members of the International Alport Syndrome consortium. We describe CECIL's features and discuss the design decisions made in generalizing CECIL's architecture.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Pearson W. R., Lipman D. J. Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2444–2448. doi: 10.1073/pnas.85.8.2444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reeders S. T. Molecular genetics of hereditary nephritis. Kidney Int. 1992 Sep;42(3):783–792. doi: 10.1038/ki.1992.348. [DOI] [PubMed] [Google Scholar]
- Zhou J., Barker D. F., Hostikka S. L., Gregory M. C., Atkin C. L., Tryggvason K. Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics. 1991 Jan;9(1):10–18. doi: 10.1016/0888-7543(91)90215-z. [DOI] [PubMed] [Google Scholar]
- Zhou J., Hertz J. M., Leinonen A., Tryggvason K. Complete amino acid sequence of the human alpha 5 (IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. J Biol Chem. 1992 Jun 25;267(18):12475–12481. [PubMed] [Google Scholar]